GNE-493
| Code | Size | Price |
|---|
| SYN-1115-M100 | 100 mg | Enquire |
Quantity:
| SYN-1115-M050 | 50 mg | Enquire |
Quantity:
| SYN-1115-M001 | 1 mg | £233.00 |
Quantity:
| SYN-1115-M005 | 5 mg | £461.00 |
Quantity:
| SYN-1115-M010 | 10 mg | £643.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
-20°C
Documents
Further Information
Alternate Names/Synonyms:
GNE493
Appearance:
Solid.
CAS:
1033735-94-2
EClass:
32160000
Form (Short):
liquid
InChi:
InChI=1S/C17H20N6O2S/c1-17(2,24)12-7-11-13(26-12)15(23-3-5-25-6-4-23)22-14(21-11)10-8-19-16(18)20-9-10/h7-9,24H,3-6H2,1-2H3,(H2,18,19,20)
InChiKey:
LEXMMFPAPDGYGZ-UHFFFAOYSA-N
Long Description:
Chemical. CAS: 1033735-94-2. Formula: C17H20N6O2S. MW: 372.4. GNE-493 is a potent, selective, and orally available pan-PI3-kinase and dual pan-PI3-kinase/mTOR inhibitor for the treatment of cancer.
Molecular Formula:
C17H20N6O2S
Molecular Weight:
372.4
Package Type:
Plastic Vial
Product Description:
GNE-493 is a potent, selective, and orally available pan-PI3-kinase and dual pan-PI3-kinase/mTOR inhibitor for the treatment of cancer.
Purity:
>95%
Solubility Chemicals:
Soluble in DMSO.
Transportation:
Non-hazardous
UNSPSC Category:
Protein Kinase Modulators
UNSPSC Number:
12352200
Use & Stability:
Stable for at least 2 years after receipt when stored at -20°C.
References
Discovery of (thienopyrimidin-2-yl)aminopyrimidines as potent, selective, and orally available pan-PI3-kinase and dual pan-PI3-kinase/mTOR inhibitors for the treatment of cancer: D.P. Sutherlin, et al.; J. Med. Chem. 53, 1086 (2010) | Rational design of phosphoinositide 3-kinase alpha inhibitors that exhibit selectivity over the phosphoinositide 3-kinase beta isoform: T.P. Heffron, et al.; J. Med. Chem. 54, 7815 (2011)
Related Products
| Product Name | Product Code | Supplier | GNE-490 | SYN-1114 | AdipoGen Life Sciences | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GNE-477 | SYN-1148 | AdipoGen Life Sciences | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||